In addition to the work performed with ALDH/CD44, we have also performed extensive testing of three additional putative stem cell marker combinations (CD10/CD24, CD44/CD24, CD10/CD44) to determine if these markers could enrich for cancer stem cells in vivo. The gene discussed is MME; the disease is cancer.